The U.S. Food and Drug Administration (FDA) has approved Lasix ONYU (furosemide injection), a new drug-device combination ...

IV ketamine for severe resistant depression is associated with a more rapid response and greater reduction of symptoms than intranasal esketamine, research shows.

CHICAGO, IL October 07, 2025 – PRESSADVANTAGE – IV Solution & Ketamine Centers of Chicago has released a comprehensive collection of patient testimonial videos documenting successful treatment ...

A new Alzheimer’s treatment is now being offered at Hancock Health, and it is giving families renewed hope in the fight ...

A new study argues that the IV hydration industry operates with almost no regulation and little medical evidence to support ...

WEDNESDAY, Oct. 8, 2025 (HealthDay News) — IV hydration spas are popping up across the United States, offering pricey vitamin ...

By Jessie OsborneFor the first time in half a century, America stands on the threshold of sending astronauts back to the Moon. Slated for launch no earlier than ...

IV Solution and Ketamine Centers of Chicago continues to demonstrate the transformative impact of its specialized mental ...

IV Solution and Ketamine Centers of Chicago continues to advance treatment options for post-traumatic stress disorder through specialized ketamine infusion protocols, addressing a critical need among ...

Zimbabwe is experiencing a degree of macroeconomic stability due to monetary policy tightening. After a sharp slowdown in 2024, economic activity ...

Operating expenses in the fourth quarter of fiscal 2025 were $2.3 million compared with $1.3 million in the same period in fiscal 2024. Net loss in the fourth quarter of fiscal 2025 was $2.1 million, ...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: ...